159 related articles for article (PubMed ID: 18984015)
1. Identification of amino acid residues involved in 4-chloroindole 3-hydroxylation by cytochrome P450 2A6 using screening of random libraries.
Zhang ZG; Liu Y; Guengerich FP; Matse JH; Chen J; Wu ZL
J Biotechnol; 2009 Jan; 139(1):12-8. PubMed ID: 18984015
[TBL] [Abstract][Full Text] [Related]
2. Analysis of coumarin 7-hydroxylation activity of cytochrome P450 2A6 using random mutagenesis.
Kim D; Wu ZL; Guengerich FP
J Biol Chem; 2005 Dec; 280(48):40319-27. PubMed ID: 16207711
[TBL] [Abstract][Full Text] [Related]
3. Random mutagenesis of human cytochrome p450 2A6 and screening with indole oxidation products.
Nakamura K; Martin MV; Guengerich FP
Arch Biochem Biophys; 2001 Nov; 395(1):25-31. PubMed ID: 11673862
[TBL] [Abstract][Full Text] [Related]
4. Expansion of substrate specificity of cytochrome P450 2A6 by random and site-directed mutagenesis.
Wu ZL; Podust LM; Guengerich FP
J Biol Chem; 2005 Dec; 280(49):41090-100. PubMed ID: 16215230
[TBL] [Abstract][Full Text] [Related]
5. Directed-evolution analysis of human cytochrome P450 2A6 for enhanced enzymatic catalysis.
Lee H; Kim JH; Han S; Lim YR; Park HG; Chun YJ; Park SW; Kim D
J Toxicol Environ Health A; 2014; 77(22-24):1409-18. PubMed ID: 25343290
[TBL] [Abstract][Full Text] [Related]
6. Identification of Val117 and Arg372 as critical amino acid residues for the activity difference between human CYP2A6 and CYP2A13 in coumarin 7-hydroxylation.
He XY; Shen J; Hu WY; Ding X; Lu AY; Hong JY
Arch Biochem Biophys; 2004 Jul; 427(2):143-53. PubMed ID: 15196988
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of 7-ethoxycoumarin, safrole, flavanone and hydroxyflavanone by cytochrome P450 2A6 variants.
Uno T; Obe Y; Ogura C; Goto T; Yamamoto K; Nakamura M; Kanamaru K; Yamagata H; Imaishi H
Biopharm Drug Dispos; 2013 Mar; 34(2):87-97. PubMed ID: 23112005
[TBL] [Abstract][Full Text] [Related]
8. Structural insight into the altered substrate specificity of human cytochrome P450 2A6 mutants.
Sansen S; Hsu MH; Stout CD; Johnson EF
Arch Biochem Biophys; 2007 Aug; 464(2):197-206. PubMed ID: 17540336
[TBL] [Abstract][Full Text] [Related]
9. Oxidation of indole by cytochrome P450 enzymes.
Gillam EM; Notley LM; Cai H; De Voss JJ; Guengerich FP
Biochemistry; 2000 Nov; 39(45):13817-24. PubMed ID: 11076521
[TBL] [Abstract][Full Text] [Related]
10. Substrate Selectivities and Catalytic Activities of Marmoset Liver Cytochrome P450 2A6 Differed from Those of Human P450 2A6.
Uehara S; Uno Y; Inoue T; Sasaki E; Yamazaki H
Drug Metab Dispos; 2015 Jul; 43(7):969-76. PubMed ID: 25858611
[TBL] [Abstract][Full Text] [Related]
11. Analysis of human cytochrome P450 2C8 substrate specificity using a substrate pharmacophore and site-directed mutants.
Melet A; Marques-Soares C; Schoch GA; Macherey AC; Jaouen M; Dansette PM; Sari MA; Johnson EF; Mansuy D
Biochemistry; 2004 Dec; 43(49):15379-92. PubMed ID: 15581350
[TBL] [Abstract][Full Text] [Related]
12. Kinetic analysis of oxidation of coumarins by human cytochrome P450 2A6.
Yun CH; Kim KH; Calcutt MW; Guengerich FP
J Biol Chem; 2005 Apr; 280(13):12279-91. PubMed ID: 15665333
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 BM-3 evolved by random and saturation mutagenesis as an effective indole-hydroxylating catalyst.
Li HM; Mei LH; Urlacher VB; Schmid RD
Appl Biochem Biotechnol; 2008 Jan; 144(1):27-36. PubMed ID: 18415984
[TBL] [Abstract][Full Text] [Related]
14. Key residues controlling binding of diverse ligands to human cytochrome P450 2A enzymes.
DeVore NM; Smith BD; Wang JL; Lushington GH; Scott EE
Drug Metab Dispos; 2009 Jun; 37(6):1319-27. PubMed ID: 19251817
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of new indigoid inhibitors of protein kinases using recombinant cytochrome P450 2A6.
Wu ZL; Aryal P; Lozach O; Meijer L; Guengerich FP
Chem Biodivers; 2005 Jan; 2(1):51-65. PubMed ID: 17191919
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of allelic variants of polymorphic human cytochrome P450 2A6 (CYP2A6*5, *7, *8, *18, *19, and *35).
Han S; Choi S; Chun YJ; Yun CH; Lee CH; Shin HJ; Na HS; Chung MW; Kim D
Biol Pharm Bull; 2012; 35(3):394-9. PubMed ID: 22382327
[TBL] [Abstract][Full Text] [Related]
17. Effects of eleven isothiocyanates on P450 2A6- and 2A13-catalyzed coumarin 7-hydroxylation.
von Weymarn LB; Chun JA; Knudsen GA; Hollenberg PF
Chem Res Toxicol; 2007 Sep; 20(9):1252-9. PubMed ID: 17672516
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of cytochrome P450 2A6 allelic variants CYP2A6*15, CYP2A6*16, CYP2A6*21, and CYP2A6*22.
Tiong KH; Yiap BC; Tan EL; Ismail R; Ong CE
Drug Metab Dispos; 2010 May; 38(5):745-51. PubMed ID: 20139165
[TBL] [Abstract][Full Text] [Related]
19. Selection of human cytochrome P450 1A2 mutants with enhanced catalytic activity for heterocyclic amine N-hydroxylation.
Kim D; Guengerich FP
Biochemistry; 2004 Feb; 43(4):981-8. PubMed ID: 14744142
[TBL] [Abstract][Full Text] [Related]
20. N-Nitrosobenzylmethylamine hydroxylation and coumarin 7-hydroxylation: catalysis by rat esophageal microsomes and cytochrome P450 2A3 and 2A6 enzymes.
von Weymarn LB; Felicia ND; Ding X; Murphy SE
Chem Res Toxicol; 1999 Dec; 12(12):1254-61. PubMed ID: 10604876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
